Targeting the Actin Nucleation Promoting Factor WASp Provides a Therapeutic Approach for Hematopoietic Malignancies

Since Wiskott–Aldrich Syndrome protein (WASp) is exclusively expressed in hematopoietic cells, scientists performed in silico screening to identify small molecule compounds that bound WASp and promoted its degradation.